BioCentury | Aug 4, 2014
Clinical News

iCo-007: Phase II data

...OTCQX:ICOTF), Vancouver, B.C. Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Product: iCo-007 Business: Ophthalmic Molecular target: c-raf mRNA...
BioCentury | Jun 24, 2013
Clinical News

iCo-007: Completed Phase II enrollment

...TSX-V:ICO), Vancouver, B.C. Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Product: iCo-007 Business: Ophthalmic Molecular target: c-raf mRNA...
BioCentury | Aug 22, 2011
Clinical News

iCo-007: Phase II started

...TSX-V:ICO), Vancouver, B.C. Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Product: iCo-007 Business: Ophthalmic Molecular target: c-raf mRNA...
BioCentury | May 24, 2010
Clinical News

iCo-007: Final Phase I data

...TSX-V:ICO), Vancouver, B.C. Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Product: iCo-007 Business: Ophthalmic Molecular target: c-raf mRNA...
BioCentury | Dec 21, 2009
Clinical News

iCo-007: Preliminary Phase I data

...TSX-V:ICO), Vancouver, B.C. Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Product: iCo-007 Business: Ophthalmic Molecular target: c-raf mRNA...
BioCentury | Jul 13, 2009
Clinical News

iCo-007: Phase I ongoing

...TSX-V:ICO), Vancouver, B.C. Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Product: iCo-007 Business: Ophthalmic Molecular target: c-raf mRNA...
BioCentury | Sep 29, 2008
Clinical News

iCo-007: Phase I data

...Vancouver, B.C. Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Product: iCo-007 Business: Ophthalmic Molecular target: c-raf mRNA...
BioCentury | Oct 15, 2007
Clinical News

iCo-007: Phase I started

...Vancouver, B.C. Isis Pharmaceuticals Inc. (ISIS), Carlsbad, Calif. Product: iCo-007 Business: Ophthalmic Molecular target: c-raf mRNA...
BioCentury | Jan 29, 2007
Clinical News

iCo-007: Phase I start

...Vancouver, B.C. Isis Pharmaceuticals Inc. (ISIS), Carlsbad, Calif. Product: iCo-007 Business: Ophthalmic Molecular target: c-raf mRNA...
BioCentury | Jan 8, 2007
Clinical News

iCo-007: IND submitted

...Vancouver, B.C. Isis Pharmaceuticals Inc. (ISIS), Carlsbad, Calif. Product: iCo-007 Business: Ophthalmic Molecular target: c-raf mRNA...
Items per page:
1 - 10 of 12